source
- Opinion: How Kennedy and MAHA could help stop measlesKennedy and MAHA say they aren’t anti-vaccine. They can prove it by promoting the MMR vaccine, writes Brinda Adhikari.STAT · 57m ago↗ source
- Merck’s TROP2 ADC extends survival in pivotal gastroesophageal cancer trialMerck & Co.’s sacituzumab tirumotecan has improved overall survival in a phase 3 cancer trial, delivering a second pivotal global victory for the TROP2-directed antibody-drug conjugate.